Book Reviews
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Cerebrovascular Disease: Momentum at the End of the Second Millennium
edited by Dennis W. Choi, MD, PhD; Ralph G. Dacey, Jr, MD; Chung Y. Hsu, MD, PhD; and William Powers, MD,
455 pp., Armonk, NY, Futura Publishing, 2001, $125
Cerebrovascular Disease: Momentum at the End of the Second Millennium is part of an American Heart Association monograph series. It is a summation of information presented at the 21st Princeton Conference on Cerebrovascular Disease held in St. Louis, MO, on May 7 to 10, 1998. The book, as was the conference, is divided into eight sections with three to seven short chapters per section. The section topics are variable, ranging from clearly clinical topics such as extracranial–intracranial bypass surgery and clinical treatment trials to more basic science/animal research studies such as mediators and modulators of ischemic injury and delayed neuronal death.
“Section I. Extracranial–Intracranial Bypass Surgery: Time for a New Clinical Trial” explores the rationale for reintroducing extracranial–intracranial bypass surgery as a potential therapy for patients with internal carotid artery occlusion based on information gained from new neuroimaging techniques, namely, PET scanning. In fact, the Carotid Occlusion Surgery Study has been funded by the National Institute of Neurological Disorders and Stroke and is randomizing patients. “Section II. Mediators and Modulators of Ischemic Injury: Hot Topics” discusses the roles of poly(ADP-ribose) polymerase and superoxide dismutase in cerebral ischemia and the potential neuroprotectant roles of estrogens and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. The titles of the next two sections, “Section III. White Matter Ischemia—Unique Mechanisms of Injury?” and “Section IV. Inflammation,” are fairly self-explanatory. However, …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David Beversdorf and Dr. Ryan Townley
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Articles
Clustering of ALS patients in central Italy due to the occurrence of the L84F SOD1 gene mutationM. Ceroni, A. Malaspina, T.E. Poloni et al.Neurology, September 01, 1999 -
Article
Unraveling ALS due to SOD1 mutation through the combination of brain and cervical cord MRIFederica Agosta, Edoardo Gioele Spinelli, Ivan V. Marjanovic et al.Neurology, January 24, 2018 -
CONFERENCE SUMMARY
Summary of `Superoxide Dismutase (SOD) and Free Radicals in Amyotrophic Lateral Sclerosis and Neurodegeneration' conferenceRaymond R. Roos, Teepu Siddique, John A. Tainer et al.Neurology, September 01, 1995 -
Amyotrophic lateral sclerosis
Phenotype and genotype analysis in amyotrophic lateral sclerosis with TARDBP gene mutationsP. Corcia, P. Valdmanis, S. Millecamps et al.Neurology, April 25, 2012